These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1764629)

  • 1. A comparative study of the actions of tamoxifen, estrogen and progesterone in the ovariectomized rat.
    Kalu DN; Salerno E; Liu CC; Echon R; Ray M; Garza-Zapata M; Hollis BW
    Bone Miner; 1991 Nov; 15(2):109-23. PubMed ID: 1764629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
    Ke HZ; Chen HK; Qi H; Pirie CM; Simmons HA; Ma YF; Jee WS; Thompson DD
    Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal response of ovariectomized rats to low and high doses of 17 beta-estradiol.
    Kalu DN; Liu CC; Salerno E; Hollis B; Echon R; Ray M
    Bone Miner; 1991 Sep; 14(3):175-87. PubMed ID: 1932891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.
    Frolik CA; Bryant HU; Black EC; Magee DE; Chandrasekhar S
    Bone; 1996 Jun; 18(6):621-7. PubMed ID: 8806005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
    Kangas L; Härkönen P; Väänänen K; Peng Z
    Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model.
    Ke HZ; Chen HK; Simmons HA; Qi H; Crawford DT; Pirie CM; Chidsey-Frink KL; Ma YF; Jee WS; Thompson DD
    Bone; 1997 Jan; 20(1):31-9. PubMed ID: 8988345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estrogen and progesterone on tibia histomorphometry in growing rats.
    Schmidt IU; Wakley GK; Turner RT
    Calcif Tissue Int; 2000 Jul; 67(1):47-52. PubMed ID: 10908413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent effects of tamoxifen on long bones in growing rats: influence of ovarian status.
    Moon LY; Wakley GK; Turner RT
    Endocrinology; 1991 Sep; 129(3):1568-74. PubMed ID: 1874188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen modulates the mRNA levels for cancellous bone protein of ovariectomized rats.
    Salih MA; Liu CC; Arjmandi BH; Kalu DN
    Bone Miner; 1993 Dec; 23(3):285-99. PubMed ID: 8148671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of estrogen and tamoxifen on serum osteocalcin levels in ovariectomized rats.
    Williams DC; Paul DC; Black LJ
    Bone Miner; 1991 Sep; 14(3):205-20. PubMed ID: 1932893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen and growth hormone on skeleton in the ovariectomized rat with hypophysectomy.
    Yeh JK; Chen MM; Aloia JF
    Am J Physiol; 1997 Oct; 273(4):E734-42. PubMed ID: 9357803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone.
    McNeill AM; Zhang C; Stanczyk FZ; Duckles SP; Krause DN
    Stroke; 2002 Jun; 33(6):1685-91. PubMed ID: 12053012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways.
    Syed FA; Mödder UI; Fraser DG; Spelsberg TC; Rosen CJ; Krust A; Chambon P; Jameson JL; Khosla S
    J Bone Miner Res; 2005 Nov; 20(11):1992-2001. PubMed ID: 16234973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of aging on cortical and trabecular bone response to estradiol treatment in ovariectomized rats.
    Gaumet N; Braillon P; Seibel MJ; Pointillart A; Coxam V; Davicco MJ
    Gerontology; 1998; 44(3):132-9. PubMed ID: 9592683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats.
    Turner RT; Wakley GK; Hannon KS; Bell NH
    Endocrinology; 1988 Mar; 122(3):1146-50. PubMed ID: 3342747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin.
    Goulding A; Gold E; Feng W
    Bone Miner; 1992 Aug; 18(2):143-52. PubMed ID: 1525595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin induces estrogen receptor-alpha expression in bone, restores bone loss, and decreases ERα expression and uterine wet weight in ovariectomized rats.
    Li X; Song QS; Wang JY; Leng HJ; Chen ZQ; Liu ZJ; Dang GT; Song CL
    J Bone Miner Metab; 2011 Jul; 29(4):396-403. PubMed ID: 21063740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of osthole on postmenopausal osteoporosis using ovariectomized rats; comparison to the effects of estradiol.
    Li XX; Hara I; Matsumiya T
    Biol Pharm Bull; 2002 Jun; 25(6):738-42. PubMed ID: 12081139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.